News & Events about Cutera Inc.
Cutera (NASDAQ:CUTR Get Rating) had its price target reduced by Maxim Group from $80.00 to $55.00 in a report issued on Thursday, The Fly reports. They currently have a buy rating on the medical device companys stock. Several other research analysts also recently commented on CUTR. Cantor Fitzgerald...
Cutera, Inc. (Nasdaq: CUTR) (Cutera or the Company), a leading provider of aesthetic and dermatology solutions, today announced certain preliminary, unaudited financial results for the year ended December 31, 2022. These results are subject to the completion of the Companys year-end financial...
Business Wire
2 months ago
Cutera, Inc. (Nasdaq: CUTR) ('Cutera' or the 'Company'), a leading provider of aesthetic and dermatology solutions, today announces that AviClear is now broadly available to physicians and practitioners treating patients throughout North America. AviClear is the first and only...
Business Wire
3 months ago
Cutera, Inc. (Nasdaq: CUTR) ('Cutera' or the 'Company'), a leading provider of aesthetic and dermatology solutions, today announced that the 12-month clinical data related to AviClear, the first and only FDA-cleared energy-based device for the treatment of mild, moderate, and...
Global Laser Therapy Devices Billion Dollar Market Thriving on Growing Demand Global Laser Therapy Devices Billion Dollar Market Thriving on Growing Demand PR Newswire PALM BEACH, Fla., Oct. 4, 2022 FinancialNewsMedia.com News Commentary PALM BEACH, Fla., Oct. 4, 2022 /PRNewswire/ -- The laser...